Matricelf Ltd Total Assets
Matricelf Ltd total assets. Based on the latest financial reports, Matricelf Ltd (MTLF) holds total assets worth ILA10.99K ILA (≈ $29.47 USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of Matricelf Ltd for the company's overall valuation and market capitalisation.
Total Assets of Matricelf Ltd (2019–2024)
Total assets of Matricelf Ltd from 2019 to 2024. This chart illustrates how Matricelf Ltd's total assets have evolved over time, based on quarterly financial data. See current stock price of Matricelf Ltd for real-time trading data and today's change.
Matricelf Ltd - Asset Composition Analysis
Matricelf Ltd Total Assets Breakdown (December 2024)
Matricelf Ltd total assets breakdown as of December 2024. Matricelf Ltd's total assets of ILA10.99K consist of 68.9% current assets and 31.1% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0.5% |
| Accounts Receivable | ILA443.00K | 2.4% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA2.61 Million | 14.2% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Matricelf Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore MTLF current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Matricelf Ltd's current assets represent 68.9% of total assets in 2024, an increase from 41.9% in 2019.
- Cash Position: Cash and equivalents constituted 0.5% of total assets in 2024, down from 39.6% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, a decrease from 57.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 14.2% of total assets.
Matricelf Ltd Competitors by Total Assets
Key competitors of Matricelf Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
HLB Co. Ltd
KQ:028300
|
Korea | ₩925.44 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Shanghai Medicilon Inc
SHG:688202
|
China | CN¥2.88 Billion |
|
Blue Jet Healthcare Limited
NSE:BLUEJET
|
India | Rs16.41 Billion |
|
Hangzhou Biotest Biotech Co Ltd
SHG:688767
|
China | CN¥2.49 Billion |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197
|
China | CN¥725.73 Million |
|
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880
|
China | CN¥3.67 Billion |
Matricelf Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.69 | 8.56 | 12.32 |
| Quick Ratio | 2.69 | 8.56 | 12.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA3.62K | ILA16.48 Million | ILA23.84 Million |
Matricelf Ltd - Advanced Valuation Insights
This section examines the relationship between Matricelf Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 1.07 |
| Asset Growth Rate (YoY) | -39.2% |
| Total Assets | ILA18.35 Million |
| Market Capitalization | $19.61 Million USD |
Valuation Analysis
Above Book Valuation: The market values Matricelf Ltd's assets above their book value (1.07x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Matricelf Ltd's assets decreased by 39.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Matricelf Ltd (2019–2024)
The table below shows the annual total assets of Matricelf Ltd from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA18.35 Million ≈ $49.20K |
-39.24% |
| 2023-12-31 | ILA30.20 Million ≈ $80.98K |
-23.52% |
| 2022-12-31 | ILA39.49 Million ≈ $105.88K |
+36.64% |
| 2021-12-31 | ILA28.90 Million ≈ $77.49K |
+387.01% |
| 2020-12-31 | ILA5.93 Million ≈ $15.91K |
+40.83% |
| 2019-12-31 | ILA4.21 Million ≈ $11.30K |
-- |
About Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more